ES8605802A1 - Procedimiento para la fabricacion de nuevos compuestos cina-moicos - Google Patents

Procedimiento para la fabricacion de nuevos compuestos cina-moicos

Info

Publication number
ES8605802A1
ES8605802A1 ES545610A ES545610A ES8605802A1 ES 8605802 A1 ES8605802 A1 ES 8605802A1 ES 545610 A ES545610 A ES 545610A ES 545610 A ES545610 A ES 545610A ES 8605802 A1 ES8605802 A1 ES 8605802A1
Authority
ES
Spain
Prior art keywords
compounds
preparation
group
therapeutical use
cinnamoyl compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES545610A
Other languages
English (en)
Other versions
ES545610A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Delalande SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delalande SA filed Critical Delalande SA
Publication of ES545610A0 publication Critical patent/ES545610A0/es
Publication of ES8605802A1 publication Critical patent/ES8605802A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA FABRICACION DE NUEVOS COMPUESTOS CINAMOICOS. CONSISTE EN HIDROLIZAR EL GRUPO ESTER DE LOS DERIVADOS (I) DE FORMULA (ID), REALIZANDOSE LA HIDROLISIS CON AYUDA DE ACIDO CLORHIDRICO DILUIDO EN ACIDO ACETICO O CON AYUDA DE ACIDO TRIFLUOROACETICO EN UN DISOLVENTE ORGANICO TAL COMO CLORURO DE METILENO, PARA LA PREPARACION DE LOS DERIVADOS (I) TRANS. SIENDO: A, UNO DE LOS CONJUNTOS DE FORMULA (II); B, GRUPO OH O UN CONJUNTO DE FORMULA (III) O BIEN CONJUNTO DE FORMULA (IV); B2, GRUPO DE FORMULA (V) O (VI); AR, NUCLEO FENILICO, NUCLEO FENILICO SUSTITUIDO, GRUPO 1,3-BENZODIOXOL, GRUPO DE ESTRUCTRA DE FORMULA (VII), ETC.; M, 0 O 1; N, 1, 2 O 3; R, 0 O 1; S, 0, 2 O 3; P, 1 O 2; Q, 1 O 2; T, 1, 2, 3 O 4; R Y R1, CADA UNO DE ELLOS, H O GRUPO METILO; R2 Y R3, CADA UNO DE ELLOS, H O GRUPO ALQUILO DE C 1 A 4; R4, H O GRUPO ALQUILO DE C 1 A 4; Y R6, GRUPO ALQUILO DE C 1 A 4. SE UTILIZA EN TERAPEUTICA.
ES545610A 1983-09-30 1985-07-26 Procedimiento para la fabricacion de nuevos compuestos cina-moicos Expired ES8605802A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8315580A FR2552762B1 (fr) 1983-09-30 1983-09-30 Nouveaux amides piperaziniques et homopiperaziniques derives de l'acide 3,4-dioxymethylene cinnamique, leur procede de preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
ES545610A0 ES545610A0 (es) 1986-04-01
ES8605802A1 true ES8605802A1 (es) 1986-04-01

Family

ID=9292689

Family Applications (5)

Application Number Title Priority Date Filing Date
ES536404A Expired ES8605799A1 (es) 1983-09-30 1984-09-29 Procedimiento para la fabricacion de nuevos compuestos cinamoicos
ES545611A Expired ES8605803A1 (es) 1983-09-30 1985-07-26 Procedimiento para la fabricacion de nuevos compuestos cina-moicos
ES545610A Expired ES8605802A1 (es) 1983-09-30 1985-07-26 Procedimiento para la fabricacion de nuevos compuestos cina-moicos
ES545609A Expired ES8605801A1 (es) 1983-09-30 1985-07-26 Procedimiento para la fabricacion de nuevos compuestos cina-moicos
ES545608A Expired ES8605800A1 (es) 1983-09-30 1985-07-26 Procedimiento para la fabricacion de nuevos compuestos cina-moicos

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES536404A Expired ES8605799A1 (es) 1983-09-30 1984-09-29 Procedimiento para la fabricacion de nuevos compuestos cinamoicos
ES545611A Expired ES8605803A1 (es) 1983-09-30 1985-07-26 Procedimiento para la fabricacion de nuevos compuestos cina-moicos

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES545609A Expired ES8605801A1 (es) 1983-09-30 1985-07-26 Procedimiento para la fabricacion de nuevos compuestos cina-moicos
ES545608A Expired ES8605800A1 (es) 1983-09-30 1985-07-26 Procedimiento para la fabricacion de nuevos compuestos cina-moicos

Country Status (9)

Country Link
US (1) US4808582A (es)
EP (1) EP0136945B1 (es)
JP (1) JPH0631227B2 (es)
AU (1) AU3368484A (es)
CA (1) CA1227195A (es)
DE (1) DE3485988T2 (es)
ES (5) ES8605799A1 (es)
FR (1) FR2552762B1 (es)
ZA (1) ZA847640B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8512163D0 (en) * 1985-05-14 1985-06-19 Fujisawa Pharmaceutical Co Oxothiazolidine compound
DK386089A (da) * 1988-08-12 1990-02-13 Japan Tobacco Inc Katekolderivater
US6867203B2 (en) 1998-12-29 2005-03-15 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
US6878700B1 (en) * 1998-12-29 2005-04-12 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
SE0003795D0 (sv) 2000-10-20 2000-10-20 Astrazeneca Ab Pharmaceutically useful compounds

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1139934A (en) * 1966-08-18 1969-01-15 Delalande Sa Cinnamylpiperazine preparations
GB1168108A (en) * 1967-09-29 1969-10-22 Delalande Sa Amide Derivatives of 1-Piperazine Acetic Acid and Process for their Preparation
GB1218591A (en) * 1968-04-03 1971-01-06 Delalande Sa Derivatives of n-(3,4,5-trimethoxy cennamoyl) piperazine and their process of preparation
US3753984A (en) * 1971-05-26 1973-08-21 Delalande Sa Amides derived from the esters of 1-piperazine propionic acid, their method of preparation and their application to therapeutics
FR2244518A1 (en) * 1973-08-10 1975-04-18 Delalande Sa N-sinapyl-N'-alkoxyalkyl or-aminocarbonylmethyl-piperazines - as vasodilators, diuretics, antihypertensive and antiulcer agents
FR2278340A1 (fr) * 1974-07-17 1976-02-13 Delalande Sa Nouveau derive de la n-(trimethoxy-3,4,5 cinnamoyl) piperazine, ses sels d'addition d'acides, son procede de preparation et son application en therapeutique
GB1473262A (en) * 1974-11-20 1977-05-11 Delalande Sa Derivatives of n-3,4,5-trimethoxy cinnamoyl-piperazine their process of preparation and their therapeutic application
FR2460942A1 (fr) * 1979-07-12 1981-01-30 Delalande Sa Nouveaux derives de l'acide a-amino butyrique, leur procede de preparation et leur application en therapeutique
JPS5732255A (en) * 1980-08-05 1982-02-20 Kowa Co Trimethoxyphenyl derivative
US4397855A (en) * 1981-06-26 1983-08-09 Warner-Lambert Company 4-(Substituted)-α, α-dimethyl-1-piperazine pentanoic acids and derivatives as anti-arteriosclerotic agents and method
JPS5888370A (ja) * 1981-11-19 1983-05-26 Hokuriku Seiyaku Co Ltd １−（３，４，５−トリメトキシシンナモイル）−４−アミノカルボニルエチル置換ピペラジン及びホモピペラジン誘導体、及びその製造方法
IT1151104B (it) * 1982-02-04 1986-12-17 Delalande Sa Impiego terapeutico di derivati (1-cinnamoil oppure 1-fenetil-carbonil)piperazinici
FR2522325B1 (fr) * 1982-02-26 1985-08-09 Delalande Sa Nouveaux derives aryliques de la piperazine, de l'homopiperazine et de n,n'-dialkyl diamino-1,2 ethane, leur procede de preparation et leur application en therapeutique

Also Published As

Publication number Publication date
US4808582A (en) 1989-02-28
DE3485988T2 (de) 1993-04-15
ES545611A0 (es) 1986-04-01
FR2552762B1 (fr) 1986-07-25
EP0136945B1 (fr) 1992-11-19
ES545608A0 (es) 1986-04-01
ES545609A0 (es) 1986-04-01
AU3368484A (en) 1985-04-04
ES8605801A1 (es) 1986-04-01
FR2552762A1 (fr) 1985-04-05
ES536404A0 (es) 1986-04-01
JPH0631227B2 (ja) 1994-04-27
ES8605799A1 (es) 1986-04-01
JPS60105662A (ja) 1985-06-11
ES8605800A1 (es) 1986-04-01
ZA847640B (en) 1985-05-29
ES8605803A1 (es) 1986-04-01
ES545610A0 (es) 1986-04-01
DE3485988D1 (de) 1992-12-24
CA1227195A (en) 1987-09-22
EP0136945A3 (en) 1985-07-10
EP0136945A2 (fr) 1985-04-10

Similar Documents

Publication Publication Date Title
EP0176034A3 (en) Diaryl acetylenes, their preparation and use
GR3032083T3 (en) Immunosuppressant and antiallergic compounds, e.g. n-(3-oxohexanoyl) homoserine lactone
ES8700660A1 (es) Un procedimiento para la preparacion de derivados de bencimidasol.
ES468173A1 (es) Un procedimiento para la preparacion de derivados de morfina
ES8900045A1 (es) Procedimiento para preparar derivados de 2-amino-tiazol
ES8702427A1 (es) Un procedimiento para preparar derivados de 1,3-difosfonato
ES8608503A1 (es) Procedimiento para la fabricacion de nuevos derivados de la cumarina
IL112098A0 (en) Sulfamate derivatives and pharmaceutical compositions containing them
HRP940458B1 (en) New bis-naphtalimides for the treatment of canser
EP0107733A4 (en) CYCLOALIPHATIC MEDICINE COMPOSITIONS.
ES8605803A1 (es) Procedimiento para la fabricacion de nuevos compuestos cina-moicos
IE893956L (en) Novel compounds
ES468170A1 (es) Un procedimiento para la preparacion de un nuevo derivado demorfina
ES8606880A1 (es) Un procedimiento para la preparacion de nuevos peptidos.
TW252979B (es)
ES8707734A1 (es) Procedimiento para la obtencion de cefalosporinas
ES8701161A1 (es) Un procedimiento para preparar derivados de piridiloxi
IE831004L (en) Long-acting theophylline in medicinal form
ES8607963A1 (es) &#34;un procedimiento para la preparacion de derivados de imi- dazol triciclicos&#34;
ES8702379A1 (es) Un procedimiento para la produccion de 1h-tetrazol-5-carboxamidas-n-sustituidas.
ES8607224A1 (es) Un procedimiento para preparar esteres de acidos (alquilsulfonil)-metanosulfonicos
CA2143000A1 (en) Non-Metabolizable Clomiphene Analogs for Treatment of Tamoxifen-Resistant Tumors
JPS55164672A (en) Azetidine derivative and its preparation
EP0302633A3 (en) Beta-lactam compound, process for preparing the same, intermediate for synthesis of the same and medicinal composition for bacterially infectious disease therapy containing the same
ES8401062A1 (es) Procedimiento para la preparacion de nuevas 1-furil-3,4-dihidroisoquinoleinas.